Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients
- 1 January 1980
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 17 (1) , 5-11
- https://doi.org/10.1007/bf00561670
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Haemodynamic effects and plasma concentrations of labetalol during long‐ term treatment of essential hypertension.British Journal of Clinical Pharmacology, 1979
- Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patientsAmerican Heart Journal, 1977
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.British Journal of Clinical Pharmacology, 1976
- Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.BMJ, 1976
- Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.Heart, 1974
- Beta adrenergic blockade in hypertension: Practical and theoretical implications of long-term hemodynamic variationsThe American Journal of Cardiology, 1972
- Thermodilution cardiac output determination with a single flow-directed catheterAmerican Heart Journal, 1972
- Control of the Splanchnic Circulation in ManCirculation Research, 1967
- The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N′-m-hydroxyphenylami-nomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effectsAmerican Heart Journal, 1953